Tracey A Wilkinson1, Ashley H Meredith2, Sally Rafie3, Amy J Katz4, Thomas L Vielott5, Carolyn G Meagher5, Mary A Ott5. 1. Indiana University School of Medicine, Department of Pediatrics/Children's Health Services Research, Indianapolis, Indiana. Electronic address: tracwilk@iu.edu. 2. Purdue University College of Pharmacy, Department of Pharmacy Practice, Indianapolis, Indiana. 3. Birth Control Pharmacist, San Diego, California. 4. Indiana University School of Medicine, Department of Pediatrics/Children's Health Services Research, Indianapolis, Indiana. 5. Indiana University School of Medicine, Department of Pediatrics/Adolescent Medicine, Indianapolis, Indiana.
Abstract
PURPOSE: Multiple states allow pharmacists to prescribe hormonal contraception but can have age restrictions. The study objective was to examine how age influences adolescents' and young adults' (AYAs) ability to self-report potential contraindications to hormonal contraception compared with physician reports (our "gold standard"). METHODS: Between February 2017 and August 2018, girls aged 14-21 years and their physicians were recruited in outpatient adolescent primary and subspecialty care clinics. Screeners were completed separately for medical conditions that are potential contraindications to hormonal contraception as defined by the Centers for Disease Control Medical Eligibility Criteria. Overall, discordance was defined as differences between the patient's and provider's answers, and potential unsafe discordance was defined as AYAs underreporting of contraindications. Multivariable logistic regression was used to examine predictors of overall and unsafe discordance. RESULTS: Of 394 AYA/physician pairs, 45% were from subspecialty clinics, 35% identified as African American, the mean age was 16.7 ± 1.9 years, and 38% were sexually active. Fifty percent of patients reported potential contraindications to hormonal contraception. There was only an 18% rate of unsafe discordance, with no statistical difference by age but a higher rate in subspecialty clinics (28% vs. 10%). No variables were predictive of higher rates of unsafe discordance in general or subspecialty clinics. CONCLUSIONS: Potential overall and unsafe discordance between AYAs' and physicians' reports of medical contraindications to combined hormonal contraception were not related to younger age and thus support expansion of pharmacy access to adolescents. Pediatric subspecialists need to proactively address hormonal contraceptive needs and safety as pharmacy access expands.
PURPOSE: Multiple states allow pharmacists to prescribe hormonal contraception but can have age restrictions. The study objective was to examine how age influences adolescents' and young adults' (AYAs) ability to self-report potential contraindications to hormonal contraception compared with physician reports (our "gold standard"). METHODS: Between February 2017 and August 2018, girls aged 14-21 years and their physicians were recruited in outpatient adolescent primary and subspecialty care clinics. Screeners were completed separately for medical conditions that are potential contraindications to hormonal contraception as defined by the Centers for Disease Control Medical Eligibility Criteria. Overall, discordance was defined as differences between the patient's and provider's answers, and potential unsafe discordance was defined as AYAs underreporting of contraindications. Multivariable logistic regression was used to examine predictors of overall and unsafe discordance. RESULTS: Of 394 AYA/physician pairs, 45% were from subspecialty clinics, 35% identified as African American, the mean age was 16.7 ± 1.9 years, and 38% were sexually active. Fifty percent of patients reported potential contraindications to hormonal contraception. There was only an 18% rate of unsafe discordance, with no statistical difference by age but a higher rate in subspecialty clinics (28% vs. 10%). No variables were predictive of higher rates of unsafe discordance in general or subspecialty clinics. CONCLUSIONS: Potential overall and unsafe discordance between AYAs' and physicians' reports of medical contraindications to combined hormonal contraception were not related to younger age and thus support expansion of pharmacy access to adolescents. Pediatric subspecialists need to proactively address hormonal contraceptive needs and safety as pharmacy access expands.
Authors: Gina M Secura; Jenifer E Allsworth; Tessa Madden; Jennifer L Mullersman; Jeffrey F Peipert Journal: Am J Obstet Gynecol Date: 2010-06-11 Impact factor: 8.661
Authors: Maria T Britto; Robert F DeVellis; Richard W Hornung; Gordon H DeFriese; Harry D Atherton; Gail B Slap Journal: Pediatrics Date: 2004-11 Impact factor: 7.124
Authors: Allison M S Verhaak; Anne Williamson; Amy Johnson; Andrea Murphy; Matthew Saidel; Abigail L Chua; Mia Minen; Brian M Grosberg Journal: Headache Date: 2020-12-30 Impact factor: 5.887
Authors: Irma M Hein; Martine C De Vries; Pieter W Troost; Gerben Meynen; Johannes B Van Goudoever; Ramón J L Lindauer Journal: BMC Med Ethics Date: 2015-11-09 Impact factor: 2.652